103 related articles for article (PubMed ID: 17959037)
21. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
22. [Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823].
Li Q; Peng J; Zhang GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 33(12):1123-8. PubMed ID: 19141979
[TBL] [Abstract][Full Text] [Related]
23. [Effects of EGFR inhibitor AG1478 in combination with celecoxib on the growth of gastric cancer cells].
Li RK; Qiang O; Liao J; Wang CH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):595-9. PubMed ID: 20848776
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 inhibition as a strategy for treating gastric adenocarcinoma.
Xiang HG; Xie X; Hu FQ; Xiao HB; Zhang WJ; Chen L
Oncol Rep; 2014 Sep; 32(3):1140-8. PubMed ID: 24992958
[TBL] [Abstract][Full Text] [Related]
25. SOM230 combined with celecoxib prolongs the survival in nude mice with HepG-2 xenografts.
Xie Y; Chen S; Wang CH; Tang CW
Cancer Biol Ther; 2011 Jul; 12(1):86-92. PubMed ID: 21532334
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.
Shaik MS; Chatterjee A; Jackson T; Singh M
Int J Cancer; 2006 Jan; 118(2):396-404. PubMed ID: 16052515
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer.
Altorki NK; Port JL; Zhang F; Golijanin D; Thaler HT; Duffield-Lillico AJ; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2005 Jun; 11(11):4191-7. PubMed ID: 15930356
[TBL] [Abstract][Full Text] [Related]
28. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
[TBL] [Abstract][Full Text] [Related]
29. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.
Kim N; Kim CH; Ahn DW; Lee KS; Cho SJ; Park JH; Lee MK; Kim JS; Jung HC; Song IS
J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436
[TBL] [Abstract][Full Text] [Related]
30. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
[TBL] [Abstract][Full Text] [Related]
31. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
Narayanan BA; Reddy BS; Bosland MC; Nargi D; Horton L; Randolph C; Narayanan NK
Clin Cancer Res; 2007 Oct; 13(19):5965-73. PubMed ID: 17908994
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect of somatostatin analogue octreotide on the expression of p53 and Ras in human gastric cancer].
Tian L; Li S
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1245-8. PubMed ID: 21764706
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer.
Guo Q; Liu X; Lu L; Yuan H; Wang Y; Chen Z; Ji R; Zhou Y
Medicine (Baltimore); 2017 Dec; 96(51):e8857. PubMed ID: 29390421
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
[TBL] [Abstract][Full Text] [Related]
35. Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells.
Park JS; Jun HJ; Cho MJ; Cho KH; Lee JS; Zo JI; Pyo H
Clin Cancer Res; 2006 Aug; 12(16):4989-99. PubMed ID: 16914589
[TBL] [Abstract][Full Text] [Related]
36. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
[TBL] [Abstract][Full Text] [Related]
37. [Effects of cetuximab combined with celecoxib on apoptosis and KDR and AQP1 expression in lung cancer].
Xia H; Ye J; Bai H; Wang C
Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):625-31. PubMed ID: 24345486
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin and cancer: applying endocrinology to oncology.
Grimberg A
Cancer Biol Ther; 2004 Aug; 3(8):731-3. PubMed ID: 15326367
[TBL] [Abstract][Full Text] [Related]
39. Low direct cytotoxicity of loxoprofen on gastric mucosal cells.
Yamakawa N; Suemasu S; Kimoto A; Arai Y; Ishihara T; Yokomizo K; Okamoto Y; Otsuka M; Tanaka K; Mizushima T
Biol Pharm Bull; 2010; 33(3):398-403. PubMed ID: 20190399
[TBL] [Abstract][Full Text] [Related]
40. Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.
Agarwala A; Fisher W; Bruetman D; McClean J; Taber D; Titzer M; Juliar B; Yu M; Breen T; Einhorn LH; Hanna N
J Thorac Oncol; 2008 Apr; 3(4):374-9. PubMed ID: 18379355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
